SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
USD
  • USD
  • MXN
  • ARS
  • EUR
Mitarbeiter 25.200

Zahlte zuletzt am 14.05.2021 eine Dividende von 1,76  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von

131 News & Informationen zur Amgen Inc. Aktie

  • Amgen (AMGN)/AstraZeneca's Asthma Drug Gets FDA Priority Tag
    zacks.com

    Amgen (AMGN)/AstraZeneca's Asthma Drug Gets FDA Priority Tag

    The FDA accepts and grants priority review to Amgen (AMGN)/AstraZeneca's BLA for tezepelumab for the treatment of asthma.

  • Tezepelumab Granted Priority Review By U.S. FDA
    prnewswire.com

    Tezepelumab Granted Priority Review By U.S. FDA

    /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and…

  • BeiGene Announces Acceptance Of A Supplemental Biologics License Application In China For Tislelizumab In Esophageal Squamous Cell...
    thestreet.com

    BeiGene Announces Acceptance Of A Supplemental Biologics License Application In China For Tislelizumab In Esophageal Squamous Cell Carcinoma (ESCC)

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today

  • Here's Why Biohaven Pharmaceutical Is Soaring Today
    fool.com

    Here's Why Biohaven Pharmaceutical Is Soaring Today

    Preliminary sales figures for the company's new migraine drug were much better than expected.

  • Global Erythropoietin Drugs Market Research Report 2021-2027: Biologics, Biosimilars, Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa
    prnewswire.com

    Global Erythropoietin Drugs Market Research Report 2021-2027: Biologics, Biosimilars, Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa

    /PRNewswire/ — The “Global Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Regional Outlook, Industry Analysis Report and Forecast,…

  • Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
    pennystocks.com

  • U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60% By Investing.com
    investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60% By Investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60%

  • Worldwide End Stage Renal Disease Industry To 2026 - High Focus On Technology Presents Opportunities
    thestreet.com

    Worldwide End Stage Renal Disease Industry To 2026 – High Focus On Technology Presents Opportunities

    DUBLIN, July 5, 2021 /PRNewswire/ — The “Global End Stage Renal Disease Market (2021-2026) by Disease Type, Treatment Type, End-user, Geography, Competitive

  • 3 Biotech Stocks To Buy As Vaccinations Continue To Climb
    investing.com

    3 Biotech Stocks To Buy As Vaccinations Continue To Climb

    Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Gilead Sciences Inc, Amgen Inc, Illumina Inc, Moderna Inc. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com

  • Labcorp : Launches Companion Diagnostic for Amgen's Newly-approved Lung Cancer Therapy
    marketscreener.com

    Labcorp : Launches Companion Diagnostic for Amgen's Newly-approved Lung Cancer Therapy

    Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer
    … | July 1, 2021

  • Photo Courtesy Of Labcorp.
    thestreet.com

    Photo Courtesy Of Labcorp.

    Labcorp ® LH, a leading global life sciences company, today announced the availability of therascreen ® KRAS PCR Mutation Analysis, a companion diagnostic to

  • US stocks close higher. S&P trades to another record close
    forexlive.com

    US stocks close higher. S&P trades to another record close

    Nasdaq lags and closes marginally higher
    The major US indices are closing the day higher with the S&P index leading the way. The S&P index is up for the six consecutive day and closes at a record level.
    By Greg Michalowski

  • Gene Therapy Market to Grow Substantially at 40.7% CAGR by 2025 - Report by Market Research Future (MRFR)
    globenewswire.com

    Gene Therapy Market to Grow Substantially at 40.7% CAGR by 2025 – Report by Market Research Future (MRFR)

    Gene Therapy Market Insights and Industry Analysis by Indication (Genetic Diseases, Oncology), By End-User (Hospitals & Clinics, Specialty Treatment…

  • 4 Unstoppable Biotech Stocks to Buy Right Now By StockNews
    investing.com

  • A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark
    etftrends.com

    A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark

    As investors consider the regulatory, scientific, and demographic factors driving today’s growth in biotechnology industry…

  • The Zacks Analyst Blog Highlights: Google, Visa, Eli Lilly, Amgen and Sony Group
    zacks.com

    The Zacks Analyst Blog Highlights: Google, Visa, Eli Lilly, Amgen and Sony Group

    The Zacks Analyst Blog Highlights: Google, Visa, Eli Lilly, Amgen and Sony Group

  • U.S. Stocks Fail To Hold Gains, Settle Flat; Nasdaq, S&P 500 Post New Highs
    markets.businessinsider.com

    U.S. Stocks Fail To Hold Gains, Settle Flat; Nasdaq, S&P 500 Post New Highs

    (RTTNews) – U.S. stocks failed to hold gains and ended flat on Tuesday as investors turned cautious and largely refrained from holding positions a…

  • U.S. Stocks Fail To Hold Gains, Settle Flat; Nasdaq, S&P 500 Post New Highs
    rttnews.com

    U.S. Stocks Fail To Hold Gains, Settle Flat; Nasdaq, S&P 500 Post New Highs

    U.S. stocks failed to hold gains and ended flat on Tuesday as investors turned cautious and largely refrained from holding positions at higher levels as they looked ahead to crucial jobs data, due later in the week.

  • Global Gene Therapy Market To Reach $2.7 Billion By 2026
    thestreet.com

    Global Gene Therapy Market To Reach $2.7 Billion By 2026

    SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Amgen Stock: A Defensive Play In An Expensive Market (NASDAQ:AMGN)
    seekingalpha.com

    Amgen Stock: A Defensive Play In An Expensive Market (NASDAQ:AMGN)

    Amgen is very stable and predictable. The balance sheet is well managed, setting the business up for future success.

  • Age-related Macular Degeneration Market In Pharmaceutical Industry | Technavio
    thestreet.com

    Age-related Macular Degeneration Market In Pharmaceutical Industry | Technavio

    NEW YORK, June 28, 2021 /PRNewswire/ — The age-related macular degeneration market will witness USD 4.00 billion growth during 2021-2025, according to the

  • Intellia Shares Soar on Positive Test Results
    gurufocus.com

    Intellia Shares Soar on Positive Test Results

    GuruFocus Article or News written by Barry Cohen and the topic is about: Merck, Sanofi, Gilead and others stand to benefit from clinical trials

  • Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent...
    marketscreener.com

    Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis

    BOSTON and JERUSALEM, June 28, 2021 — Entera Bio Ltd. , a leader in the development of orally delivered large molecule therapeutics, today announced it will conduct a conference call to… | June 28, 2021

  • Futures Pointing To Roughly Flat Open On Wall Street
    rttnews.com

    Futures Pointing To Roughly Flat Open On Wall Street

    The major U.S. index futures are currently pointing to a roughly flat open on Monday, with stocks likely to show a lack of direction following the strong upward move seen last week.

  • Invesco NASDAQ Biotech UCITS ETF: Folgt nach dem Aufschwung die Rallye?
    etf-nachrichten.de

  • U.S. Stocks Close On Firm Note; S&P 500 Hits New Record High
    rttnews.com

    U.S. Stocks Close On Firm Note; S&P 500 Hits New Record High

    U.S. stocks closed on a firm note on Friday as optimism about strong economic growth outweighed concerns about inflation, prompting traders to build up fresh positions at several counters.

  • U.S. Stocks Close On Firm Note; S&P 500 Hits New Record High
    markets.businessinsider.com

    U.S. Stocks Close On Firm Note; S&P 500 Hits New Record High

    (RTTNews) – U.S. stocks closed on a firm note on Friday as optimism about strong economic growth outweighed concerns about inflation, prompting tr…

  • Adverum Announces Changes to Management Team
    globenewswire.com

    Adverum Announces Changes to Management Team

    — Christopher J. DeRespino appointed acting CFO — — Peter Soparkar appointed COO — — Leone Patterson departs as president and CFO after five years…

  • Accelerator Life Science Partners : Expands Executive Team with Appointment of Alice Chen as Executive Vice President
    marketscreener.com

    Accelerator Life Science Partners : Expands Executive Team with Appointment of Alice Chen as Executive Vice President

    Pioneering Biotech Company Builder Adds Ronald Howell as Senior Advisor …

  • Business Law Prof Blog
    lawprofessors.typepad.com

  • Peloton Wealth Strategists Buys Thor Industries Inc, UnitedHealth Group Inc, Amgen Inc, Sells Align Technology Inc, IDEXX Laboratories Inc,...
    gurufocus.com

    Peloton Wealth Strategists Buys Thor Industries Inc, UnitedHealth Group Inc, Amgen Inc, Sells Align Technology Inc, IDEXX Laboratories Inc, Nike Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Constituent
    investopedia.com

    Constituent

    A constituent is a single stock or company that is part of a larger index such as the S&P 500 or Dow Jones Industrial Average.

  • Kroger And Plug Power Among Top Trending Stocks Today
    forbes.com

    Kroger And Plug Power Among Top Trending Stocks Today

    Many of today’s trending stocks benefited from Monday’s gains, when the broader market reclaimed some of last week’s losses. Our AI review and provides scores for today's top trending stocks.

  • 4 Companies Delivering High Levels of Value Creation
    gurufocus.com

    4 Companies Delivering High Levels of Value Creation

    GuruFocus Article or News written by Nathan Parsh and the topic is about: These names create considerable value for every dollar invested

  • Greg Sukay Joins Arcutis as Vice President of Manufacturing and Process Technologies
    globenewswire.com

    Greg Sukay Joins Arcutis as Vice President of Manufacturing and Process Technologies

    WESTLAKE VILLAGE, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused…

  • Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors
    globenewswire.com

    Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors

    SOUTH SAN FRANCISCO, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Amunix Pharmaceuticals, Inc. (“Amunix”), an immuno-oncology company leveraging its…

  • Amgen: Aimovig Approved In Japan To Suppress Onset Of Migraine Attacks In Adults
    markets.businessinsider.com

    Amgen: Aimovig Approved In Japan To Suppress Onset Of Migraine Attacks In Adults

    (RTTNews) – Amgen (AMGN) announced Wednesday that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for Aimovig (…

  • Erythropoietin (EPO) Drugs Market to Garner $14.41 Billion by 2028: Allied Market Research
    globenewswire.com

    Erythropoietin (EPO) Drugs Market to Garner $14.41 Billion by 2028: Allied Market Research

    Rise in prevalence of cancer, HIV, anemia, and kidney diseases, surge in level of awareness about the benefits of EPO therapeutics, and commercialization…

  • 3 Top Biotech Stocks To Bolster Your Portfolio By StockNews
    investing.com

  • Goldman Sachs says buy these 15 overlooked stocks that its analysts are confident will each jump at least 10% by the end of the year
    markets.businessinsider.com

    Goldman Sachs says buy these 15 overlooked stocks that its analysts are confident will each jump at least 10% by the end of the year

    A man sits on the Wall street bull near the New York Stock Exchange (NYSE) on November 24, 2020 in New York City.
    Spencer Platt/Getty Images

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero